Director's Dealing • Jan 26, 2017
Director's Dealing
Open in ViewerOpens in native device viewer
In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation), Novozymes reports the following transactions under ISIN DK0060336014, Novozymes B shares under the symbol NZYM B
| Name | Peder Holk Nielsen |
|---|---|
| Relation /category of close relation | President and CEO |
| Trading date | January 25, 2017 |
| Market | Nasdaq OMX Copenhagen A/S |
| Nature of transaction and type of financial instrument | Purchase of shares |
| Volume of transaction buy (+) / sell (-) | +27,700 |
| Value of transaction (DKK) | 6,997,574 |
January 26, 2017 Company announcement No. 5
Contact information [email protected]
Martin Riise +45 3077 0738 [email protected]
Klaus Sindahl +45 5363 0134 [email protected]
Nicolai Agerskov Kobborg +45 3077 1348 [email protected]
Novozymes is the world leader in biological solutions. Together with customers, partners and the global community, we improve industrial performance while preserving the planet's resources and helping build better lives. As the world's largest provider of enzyme and microbial technologies, our bioinnovation enables higher agricultural yields, low-temperature washing, energy-efficient production, renewable fuel and many other benefits that we rely on today and in the future. We call it Rethink Tomorrow. www.novozymes.com
Novozymes A/S CVR number: 10 00 71 27 Novozymes A/S CVR number: 10 00 71 27 LEI: 529900T6WNZXD2R3JW38
Novozymes A/S Krogshoejvej 36
2880 Bagsvaerd Denmark
Phone: +45 4446 0000
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.